Claire Mulot Selected Research

Claire Mulot Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2010
9	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2010
8	Breast Neoplasms (Breast Cancer) 01/2023 - 10/2012
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 10/2018
3	Parkinson Disease (Parkinson's Disease) 01/2018 - 08/2012
2	Carcinogenesis 01/2023 - 01/2019
2	Adenocarcinoma 01/2022 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 10/2019
1	Colitis 01/2023
1	Ulcerative Colitis 01/2023
1	Hypoxia (Hypoxemia) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Genetic Risk Score 01/2020
1	Microsatellite Instability 12/2018
1	Neuroinflammatory Diseases 11/2017
1	Neoplasm Metastasis (Metastasis) 11/2015
1	Exanthema (Rash) 01/2008
1	Eosinophilia 01/2008

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 01/2023 - 10/2012
6	Circulating Tumor DNAIBA 01/2022 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	AnthracyclinesIBA 01/2021 - 11/2015
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2015
2	LigandsIBA 01/2021 - 11/2015
2	Prion ProteinsIBA 01/2021 - 08/2019
2	ORALIT (ORS)IBA 12/2020 - 10/2019
2	XenobioticsIBA 01/2019 - 01/2018
2	Cetuximab (Erbitux)FDA Link 12/2018 - 10/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018 - 05/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2017 - 08/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Detergents (Detergent)IBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	MutagensIBA 01/2023
1	Sulindac (Copal)FDA LinkGeneric 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	AzoxymethaneIBA 01/2023
1	cyclosporin HIBA 01/2023
1	chemotactic factor inactivatorIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	mahuang-tangIBA 01/2022
1	AntigensIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Poly I-CIBA 01/2021
1	Annexin A1IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	CarcinogensIBA 01/2021
1	eryaspaseIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	SmokeIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Neuropeptide YIBA 01/2016
1	Therapeutic UsesIBA 11/2015
1	MicroRNAs (MicroRNA)IBA 01/2014
1	3' Untranslated Regions (3' UTR)IBA 01/2014
1	HLA-DR alpha-ChainsIBA 08/2012
1	HLA-DRB5 Chains (HLA DRB5)IBA 08/2012
1	Fluorouracil (Carac)FDA LinkGeneric 05/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2010
1	Minocycline (Cyclops)FDA LinkGeneric 01/2008

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
3	Adjuvant Chemotherapy 12/2018 - 11/2015
1	Chemoradiotherapy 01/2023
1	Therapeutics 01/2022
1	Duration of Therapy 10/2021
1	Immunotherapy 01/2021
1	Lab-On-A-Chip Devices 11/2015